Source:http://linkedlifedata.com/resource/pubmed/id/16289380
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2005-11-29
|
pubmed:abstractText |
Previously, we reported that metabolism of arachidonic acid through the 5-lipoxygenase (5-LOX) pathway plays an important role in the survival and growth of human prostate cancer cells. Inhibition of 5-LOX by pharmacological inhibitors triggers apoptosis in prostate cancer cells within hours of treatment, which is prevented by the metabolites of arachidonate 5-lipoxygenase, 5(S)-hydroxyeicosatetraenoic acid (5(S)-HETE), and its dehydrogenated derivative, 5-oxoeicosatetraenoic acid (5-oxoETE). These findings suggested that 5-lipoxygenase metabolites are critical survival factors of prostate cancer cells. However, molecular mechanisms by which 5(S)-HETE and its derivative 5-oxoETE exert their effects on prostate cancer cell survival are yet to be understood. Here, we report that human prostate cancer cells differentially express a G-protein-coupled 5-oxoETE receptor (5-oxoER) in them. Blocking expression of 5-oxoER by short-interfering RNA (siRNA) significantly reduced the viability of prostate cancer cells, suggesting that 5-oxoER is critical for prostate cancer cell survival, and that the 5-LOX metabolite, 5-oxoETE, controls survival of prostate cancer cells through its own G-protein-coupled receptor, 5-oxoER.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/5-oxo-6,8,11,14-eicosatetraenoic...,
http://linkedlifedata.com/resource/pubmed/chemical/Arachidonic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/OXER1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Eicosanoid
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0006-291X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
6
|
pubmed:volume |
339
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
93-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16289380-Amino Acid Sequence,
pubmed-meshheading:16289380-Apoptosis,
pubmed-meshheading:16289380-Arachidonic Acids,
pubmed-meshheading:16289380-Cell Line, Tumor,
pubmed-meshheading:16289380-Cell Survival,
pubmed-meshheading:16289380-Humans,
pubmed-meshheading:16289380-Male,
pubmed-meshheading:16289380-Molecular Sequence Data,
pubmed-meshheading:16289380-Neoplasms, Hormone-Dependent,
pubmed-meshheading:16289380-Prostatic Neoplasms,
pubmed-meshheading:16289380-RNA, Small Interfering,
pubmed-meshheading:16289380-Receptors, Eicosanoid
|
pubmed:year |
2006
|
pubmed:articleTitle |
Expression of 5-oxoETE receptor in prostate cancer cells: critical role in survival.
|
pubmed:affiliation |
Department of Urology, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI 48202, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|